Oral vinorelbine has been a well-established cytotoxic treatment for non-small cell lung cancer and metastatic breast cancer since 2004. This article summarises the applications of the drug, the advantages and challenges of using an oral agent in palliative oncology settings and how oral vinorelbine has been used to develop nurse-led services and chemotherapy outside traditional hospital environments. The article includes two case studies to place this treatment in a clinical context.
Cancer Nursing Practice. doi: 10.7748/cnp.2018.e1467
CitationFoulkes M, Farrell C, Allum T et al (2018) Oral vinorelbine: a practical approach to patient management. Cancer Nursing Practice. doi: 10.7748/cnp.2018.e1467
Peer reviewThis article has been subject to external double-blind peer review and checked for plagiarism using automated software
Correspondencemark.foulkes@royalberkshire.nhs.uk
Conflict of interestMark Foulkes has previously received honoraria for consultancy and advisory roles for Pierre Fabre Ltd
Published online: 02 May 2018
or
Are you a student? Our student subscription has content especially for you.
Find out more
